US Patent 7988998 Sustained-release tramadol formulations with 24-hour efficacy
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+257 characters)
Article
Patent abstract
A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07988998 Sustained-release tramadol formulations with 24-hour efficacy US Patent 7988998 Sustained-release tramadol formulations with 24-hour efficacy
Infobox
Patent Number
0798899800
Patent Number
798899800
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079889980
Date of Patent
August 2, 2011
0Patent Application Number
111120080
Date Filed
April 22, 2005
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079889980
Date of Patent
August 2, 2011
0Patent Application Number
111120080
Date Filed
April 22, 2005
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07988998 Sustained-release tramadol formulations with 24-hour efficacy
Infobox
Is a
Patent jurisdiction
Patent number
07988998
Date of patent
August 2, 2011
Patent application number
11112008
Date Filed
April 22, 2005
Patent primary examiner
Find more entities like US Patent 7988998 Sustained-release tramadol formulations with 24-hour efficacy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.